Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

sibutramine (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View sibutramine's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

Report a bug

Data & Metadata

Tools & Use Cases

@CFDE Workbench 2024

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Data & Metadata

Tools & Use Cases

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2024

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	Cefotaxime Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	sibutramine Compound (Entity type)	0.3529506325721741
	sibutramine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	EIF1AY Gene (Entity type)	-0.009324013
	sibutramine Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	LYPLA1 Gene (Entity type)	-0.01007753
	SID11112239 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	sibutramine Compound (Entity type)	0.2121850550174713
	Dephostatin Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	sibutramine Compound (Entity type)	0.2679176926612854
	sibutramine Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Potassium voltage-gated channel subfamily D member 3 Protein (Entity type)
	sibutramine Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Obesity Disease or Phenotype (Entity type)
	sibutramine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	S100P Gene (Entity type)	0.009405269
	sibutramine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	FBP1 Gene (Entity type)	0.009100947
	sibutramine Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	MAGEB2 Gene (Entity type)	0.00823508

Cefotaxime
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
sibutramine
Compound (Entity type)
0.3529506325721741

sibutramine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
EIF1AY
Gene (Entity type)
-0.009324013

sibutramine
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
LYPLA1
Gene (Entity type)
-0.01007753

SID11112239
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
sibutramine
Compound (Entity type)
0.2121850550174713

Dephostatin
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
sibutramine
Compound (Entity type)
0.2679176926612854

sibutramine
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Potassium voltage-gated channel subfamily D member 3
Protein (Entity type)

sibutramine
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Obesity
Disease or Phenotype (Entity type)

sibutramine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
S100P
Gene (Entity type)
0.009405269

sibutramine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
FBP1
Gene (Entity type)
0.009100947

sibutramine
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
MAGEB2
Gene (Entity type)
0.00823508

DISPLAY PER PAGE